【Brief News】Our R&D Director Dr. Zhao Lijun Invited to Attend the Shenzhen Municipal People's Congress Biopharmaceutical Industry Liaison Office Lecture Event

Recently, Dr. Zhao Lijun, Head of our R&D Department, as a corporate representative of Shenzhen Cell Valley Biopharmaceutical Co., Ltd., was invited to attend the "Deputy Lecture Hall" event organized by the Shenzhen Municipal People's Congress Biopharmaceutical Industry Liaison Office. The event specially invited President Wang Mingjun, a high-level overseas talent from Shenzhen's "Peacock Talent" program, to deliver an in-depth lecture on the theme "Prospects of the Tumor Cell Immunotherapy Industry."

Dr. Zhao Lijun, Head of our R&D Department, provided a detailed introduction to Shenzhen Cell Valley, covering the company's strategic planning, recent development updates, and research projects. As a technology-innovative small and medium-sized enterprise among the many biopharmaceutical companies in Pingshan District, Shenzhen Cell Valley has been dedicated to research and development in cell and gene therapy and cell therapy since its inception. To date, the company has established a comprehensive, integrated contract service system spanning from viral vector pipelines to cell product pipelines, extending to IIT/IND/NDA regulatory application support, and further expanding to talent cultivation within the industry.

The lecture event concluded with discussions and exchanges among attending leaders, guests, biopharmaceutical experts, and entrepreneurs. Through participation in this lecture event, an effective exchange platform for cutting-edge science and technology in the tumor immunotherapy industry was successfully established, further promoting the deepening of interdisciplinary collaboration among enterprises.